Diapharm has obtained traditional-use registration for a combination containing St John’s wort and valerian extracts for the treatment of mental exhaustion and associated insomnia.
“The combination of traditionally used herbal APIs is a valuable opportunity for advancement in this market segment,” said Dr Rainer Kolkmann, Head of Product Development at Diapharm. “By registering interesting combination products, we are paving the way to making traditional herbal active pharmaceutical ingredients interesting for the market again.”
Just a few weeks ago, Diapharm and one of its clients obtained decentralised procedure (DCP) registration in seven EU countries for the combination of St John’s wort and black cohosh for relieving the symptoms associated with menopause. The company has helped manage over 500 medicinal product registrations and marketing authorisation processes for phytopharmaceuticals throughout Europe.